Toxoplasma gondii Infection in the United States, 1999-2000

Emerging Infectious Diseases

Volumn 9, Issue 11, 2003, Pages 1371-1374

  Jones, Jeffrey L ^a,c   Kruszon Moran, Deanna ^b   Wilson, Marianna ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TOXOPLASMA GONDII ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CONGENITAL DISORDER; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH AND EXAMINATION SURVEY; NEGRO; NEUROLOGIC DISEASE; PREVALENCE; RACE DIFFERENCE; SCHOOL CHILD; SERODIAGNOSIS; STATISTICAL ANALYSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; UNITED STATES; VISUAL IMPAIRMENT;

EID: 0242355085     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0911.030098     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. CDC Recommendations regarding selected conditions affecting women's health. MMWR Morb Mortal Wkly Rep 2000;49(RR-2):59-75.
2. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR Morb Mortal Wkly Rep CDC Surveillance Summ 1999;48(SS-2):1-22.
3. Buzby JC, Roberts T. ERS updates U.S. foodborne disease costs for seven pathogens. Food Review 1996;19:20-5.
4. Roghmann MC, Faulkner CT, Lefkowitz A, Patton S, Zimmerman J, Morris G Jr, et al. Decreased seroprevalence for Toxoplasma gondii in Seventh Day Adventists in Maryland. Am J Trop Med Hyg 1999;60:790-2.
5. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-24.
6. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001;154:357-65.
7. Shah BV, Barnwell GB, Hurt PN, La Vange LM. SUDAAN user's manual, release 5.50. Research Triangle Park (NC): Research Triangle Institute; 1991.
8. Wolter KM. Introduction to variance estimation, New York: Springer-Verlag, 1990.
9. Weigel RM, Dubey JP, Siegel AM, Hoefling D, Reynold D, Herr L, et al. Prevalence of antibodies to Toxoplasma gondii in swine in Illinois in 1992. J Am Vet Med Assoc 1995;206:1747-51.
10. Smith KL, Wilson M, Hightower AW, Kelley PW, Struewing JP, Juranek DD, et al. Prevalence of Toxoplasma gondii antibodies in US military recruits in 1989: comparison with data published in 1965. Clin Infect Dis 1996;23:1182-3.
11. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JL, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: Saunders; 2001. p. 226.
12. Cook AJ, Gilbert RE, Buffolano W. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-7.
13. Feldman HA, Miller LT. Serological study of toxoplasmosis prevalence. Am J Hyg 1956;64:320-35.
14. Feldman HA. A nationwide serum survey of United States military recruits, 1962. VI. Toxoplasma antibodies. Am J Epidemiol 1965;81:385-91.